abstract
- Gottlieb RL, Vaca CE, Paredes R, et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med. 2022;386:305-15. 34937145.
In high-risk outpatients with COVID-19, remdesivir reduced COVID-19–related hospitalization or all-cause death at 28 d
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- May 2022
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Adenosine Monophosphate (MeSH)
- Alanine (MeSH)
- COVID-19 Drug Treatment (MeSH)
- Hospitalization (MeSH)
- Humans (MeSH)
- Outpatients (MeSH)
- SARS-CoV-2 (MeSH)
published in
- ACP journal club Journal